Company intelligence / Profile preview

HYPR

Guilford, Connecticut, United States

Ownership: Private
Employees: ~190
Development stage: Other

Overview

Hyperfine commercializes Swoop, the first FDA-cleared portable, ultra-low-field MRI system designed for point-of-care brain imaging. Clinical studies underway include office and emergency department evaluation, with over 100 patients enrolled and device adoption in US and international settings. The device has FDA 510(k) clearance, CE mark, and UKCA mark authorizations.

Therapeutic areas: Neurology
Modalities: Device
Industry: Medical Imaging

Partnerships

Takeda PharmaceuticalsCVS HealthHospitals, health systems, research institutions (exact list not publicly specified)

Beyond the preview

Go deeper on HYPR.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HYPR.

Explore the full profile